CHICAGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced the appointment of Dr. Dimitrios Iliopoulos to its Advisory Board, where he will support the Company’s biotechnology initiatives, with a focus on AI-driven drug discovery and clinical-stage therapeutic development. Dr. Iliopoulos is a world-renowned expert in artificial intelligence, drug discovery, and drug development. ...

CHICAGO, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today highlighted the intrinsic value of its wholly owned real estate portfolio and announced that it is evaluating strategic monetization options to unlock shareholder value. Based on independent valuation reports, recent market data, and comparable transactions, management estimates the combined fair market value of the Company’s Cana ...

Core Insights - Cosmos Health Inc. is expanding its retail presence in the UK by making its antimicrobial skin cleanser, C-Scrub, available through Superdrug, the second-largest beauty and health retailer in the UK [1][4]. Company Overview - Cosmos Health Inc. is a diversified, vertically integrated global healthcare group established in 2009, with a portfolio of proprietary pharmaceutical and nutraceutical brands [5]. - The company manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices under European Good Manufacturing Practices (GMP) and is certified by the European Medicines Agency (EMA) [5]. - Cosmos Health distributes a wide range of pharmaceuticals and parapharmaceuticals, including branded generics and OTC medications, through subsidiaries in Greece and the UK [5]. Product Details - C-Scrub is a powerful antiseptic wash designed to reduce bacteria and help prevent infection, thereby supporting effective skin hygiene [4]. - The product's availability in Superdrug's extensive retail and pharmacy network enhances Cosmos Health's market positioning in the UK [4]. Strategic Importance - The entry into Superdrug reinforces the retail momentum for C-Scrub in the UK and strengthens the company's market positioning across various retail platforms [5]. - This expansion is expected to increase brand reach and support the long-term development of Cosmos Health's broader product portfolio in the region [5].

CHICAGO, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced a significant expansion of its United Kingdom (UK) retail footprint as its antimicrobial skin cleanser, C-Scrub Wash Chlorhexidine 4% (“C-Scrub”), is now available through Tesco, the UK’s largest retailer. Tesco is a leading multinational retail group operating across multiple markets and ranked among the top 20 retailer ...

Corporate Updates - China SXT Pharmaceuticals, Inc. (SXTC) surged 17.40% to $0.12 after announcing a registered direct offering valued at about $10 million, selling 66,666,666 Class A ordinary shares at $0.15 per share, strengthening its balance sheet and fueling investor optimism [2] - Rapid Micro Biosystems, Inc. (RPID) advanced 8.55% to $3.30 following the release of preliminary unaudited fourth-quarter and full-year 2025 revenue results, sparking a positive reaction in extended trading [3] - TG Therapeutics, Inc. (TGTX) gained 6.99% to $29.82 after announcing preliminary U.S. net product revenue for its multiple sclerosis therapy BRIUMVI for the fourth quarter and full year 2025, along with 2026 financial guidance and development milestones [4] - argenx SE (ARGX) rose 2.00% to $826.72 after the FDA accepted for priority review a supplemental Biologics License Application for VYVGART, with a PDUFA target action date of May 10, 2026, indicating potential for expanded indications [5] - Clene Inc. (CLNN) edged higher by 0.98% to $5.15 after announcing an in-person Type C Meeting with the FDA, representing an important step in advancing its pipeline [6] Market Reactions - Cosmos Health Inc. (COSM) climbed 6.09% to $0.4961 despite no company-specific news, highlighting speculative interest and momentum trading in the micro-cap healthcare space [3] - Entera Bio Ltd. (ENTX) gained 4.11% to $1.52 in after-hours trading, reflecting investor activity around small-cap biotech names despite no new corporate updates [7]

Core Viewpoint - Cosmos Health (NASDAQ:COSM) has historically been viewed as a company that investors respect and follow, but it has not been a primary focus for investment activity [1] Company Summary - Cosmos Health has maintained a consistent presence in the market, characterized by a stable reputation among investors [1] - The company has not experienced significant urgency from investors, indicating a cautious approach towards its stock [1]

Core Insights - Motorsport Games Inc. specializes in developing and publishing racing video games, catering to motorsport enthusiasts in a competitive industry [1] - The company has a favorable Return on Invested Capital (ROIC) of 17.83% compared to its Weighted Average Cost of Capital (WACC) of 13.59), resulting in a positive ROIC to WACC ratio of 1.31, indicating efficient capital utilization [2][6] Comparison with Peers - Genius Group Limited has a negative ROIC of -24.56% and a WACC of 22.71%, leading to a negative ROIC to WACC ratio of -1.08, suggesting insufficient returns to cover its cost of capital [3] - Versus Systems Inc. shows a significantly negative ROIC of -60.78% against a WACC of 13.17%, resulting in a ROIC to WACC ratio of -4.61, highlighting severe inefficiencies in capital utilization [4] - Cosmos Health Inc. and Magic Empire Global Limited also exhibit negative ROIC to WACC ratios of -2.49 and -0.48, respectively, indicating struggles in generating adequate returns compared to Motorsport Games Inc. [5][6]

Core Insights - Motorsport Games Inc. (NASDAQ:MSGM) specializes in developing and publishing racing video games, catering to motorsport enthusiasts in a competitive industry [1] - The company demonstrates efficient capital utilization with a Return on Invested Capital (ROIC) of 17.83% and a Weighted Average Cost of Capital (WACC) of 13.75%, resulting in a favorable ROIC to WACC ratio of 1.30 [2][5] Peer Comparison - Genius Group Limited (GNS) has a negative ROIC of -24.56% and a WACC of 24.70%, leading to a ROIC to WACC ratio of -0.99, indicating insufficient returns [3] - Versus Systems Inc. (VS) shows a negative ROIC of -60.78% against a WACC of 13.12%, resulting in a ROIC to WACC ratio of -4.63, suggesting struggles in generating returns [3] - Cosmos Health Inc. (COSM) and Magic Empire Global Limited (MEGL) also report negative ROIC to WACC ratios of -2.21 and -0.48, respectively [4] - Mobile Global Esports Inc. (MGAM) has the most significant negative ratio of -55.58, indicating severe inefficiencies [4] - These comparisons highlight MSGM's superior capital efficiency relative to its peers [5]

Core Insights - Cosmos Health Inc. has acquired an additional $200,000 worth of Ethereum, increasing its total investment in ETH to $2 million [1][2][3] - The acquisition is part of a broader strategy supported by a $300 million digital assets facility aimed at diversifying and strengthening the company's portfolio through targeted digital asset investments [2][3] Company Overview - Cosmos Health Inc. is a diversified, vertically integrated global healthcare group, incorporated in 2009 in Nevada [3] - The company owns a portfolio of proprietary pharmaceutical and nutraceutical brands and operates manufacturing under European Good Manufacturing Practices (GMP) [3] - It distributes a wide range of pharmaceuticals and parapharmaceuticals through subsidiaries in Greece and the UK, and has established R&D partnerships targeting major health disorders [3] - The company has entered the telehealth space through the acquisition of ZipDoctor, Inc. and is expanding its operations globally [3]

Core Viewpoint - Motorsport Games Inc. (NASDAQ:MSGM) is underperforming in terms of capital efficiency, as indicated by its negative Return on Invested Capital (ROIC) compared to its Weighted Average Cost of Capital (WACC) [2][6]. Financial Metrics Summary - Motorsport Games Inc. has a ROIC of -28.03% and a WACC of 13.73%, resulting in a ROIC to WACC ratio of -2.04, indicating insufficient returns to cover its cost of capital [2][6]. - Genius Group Limited (GNS) has a ROIC of -29.47% and a WACC of 25.16%, leading to a ROIC to WACC ratio of -1.17, which is less negative than MSGM's but still indicates inefficiency [3]. - Versus Systems Inc. (VS) shows a ROIC of -47.17% and a WACC of 16.17%, resulting in a ROIC to WACC ratio of -2.92, indicating even lower efficiency than MSGM [4]. - Cosmos Health Inc. (COSM) has a ROIC of -33.52% and a WACC of 17.85%, with a ROIC to WACC ratio of -1.88, slightly better than MSGM but still negative [4]. - Magic Empire Global Limited (MEGL) has the highest ROIC to WACC ratio among peers at -0.48, with a ROIC of -7.64% and a WACC of 15.98%, indicating it is closer to covering its cost of capital [5]. - Mobile Global Esports Inc. (MGAM) presents the most concerning figures with a ROIC of -351.37% and a WACC of 4.64%, resulting in a ROIC to WACC ratio of -75.66, highlighting severe inefficiencies [5][6].